Physician profile
Daniel C Surowiec
NPI 1821001520
$2,519.86
in general payments reported to CMS, 2019-2025
23 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $83.94 · 2021: $140 · 2022: $172 · 2023: $471 · 2024: $718 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,995.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,240.05 | 2019-2025 | Nushield, Puraply, Puraply Wound Matrix |
| Smith+Nephew, INC. | $350.73 | 2019-2025 | Collagenase Santyl, Grafix Pl, Grafix |
| Kerecis Limited | $283.66 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Depuy Synthes Sales INC. | $86.60 | 2022-2025 | Motoband |
| Polynovo North America LLC | $58.45 | 2023-2025 | Novosorb Btm |
| Stryker Corporation | $55.13 | 2022-2023 | Ortholoc 2 Lapifuse |
| Paragon 28, INC. | $53.85 | 2024-2025 | Tenotac, Mtp |
| Paratek Pharmaceuticals, INC. | $41.38 | 2024 | Nuzyra |
| Convatec INC. | $37.13 | 2024 | |
| Ets Wound Care LLC | $36.75 | 2024 | Mirragen Advanced Wound Matrix |
| Treace Medical Concepts, INC. | $32.47 | 2024 | |
| Biocomposites INC | $31.95 | 2024 | |
| Solventum Corporation | $31.79 | 2025 | Prevena, Activ.A.C. |
| Medline Industries LP | $24.69 | 2023 | |
| Nevro Corp. | $22.32 | 2023 | Senza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $22.16 | 2025 | Celleraterx |
| Orthofix Medical, INC. | $18.71 | 2024 | Physio-Stim |
| Horizon Therapeutics Plc | $17.97 | 2023 | Krystexxa |
| Amgen INC. | $17.61 | 2024 | Krystexxa |
| Djo, LLC | $15.78 | 2024 | Cmf |
| Acera Surgical, INC. | $15.55 | 2023 | Restrata Wound Matrix |
| Mimedx Group, INC. | $13.75 | 2025 | |
| Integra Lifesciences Corporation | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Surowiec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.